M28 Capital Management LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
M28 Capital Management LP disclosed 11 US equity positions worth $73.0m in its Q1 2025 13F filing. The largest position was WVE at 62.7% of the reported book, followed by TGTX and IVVD. Against the Q4 2024 filing, it opened 0 new positions, added to 0 and reduced 1 among the top 11 holdings.
What did M28 Capital Management LP own in Q1 2025? Top 11 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 62.7% | $45.8m | 5,664,548 | 0% | held |
| 2 | TGTX TG THERAPEUTICS INC | Healthcare | 8.7% | $6.4m | 161,600 | 0% | held |
| 3 | IVVD INVIVYD INC | Healthcare | 7.7% | $5.6m | 9,248,250 | 0% | held |
| 4 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.7% | $4.2m | 121,200 | 0% | held |
| 5 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 3.5% | $2.6m | 385,680 | 0% | held |
| 6 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 3.3% | $2.4m | 55,200 | -50% | reduced | |
| 7 | GUTS FRACTYL HEALTH INC | 3.0% | $2.2m | 1,856,117 | 0% | held | |
| 8 | PROQR THRAPEUTICS N V | 1.9% | $1.4m | 1,019,498 | 0% | held | |
| 9 | CRIS CURIS INC | 1.5% | $1.1m | 521,059 | 0% | held | |
| 10 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.2% | $858.7k | 67,400 | 0% | held |
| 11 | SLN SILENCE THERAPEUTICS PLC | 0.7% | $522.0k | 185,100 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.